Subjects
#1 in Business Subscribe Email Print

You are here: Home > Business > Marketing > It's the Marketing that Counts

Tags

  • there
  • process
  • business
  • companies involved
  • companies involved

  • Links

  • Credit Card Scam Can Cost You Dearly
  • Jewelry Is Its Own Decoration
  • Buying Guide to Graphics Cards Contents
  • Subjects - It's the Marketing that Counts

    Many years ago I went into one business as CEO. The Business was los
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ing ?1m annually. Casually wandering around (listening and communica
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ing) I asked a member of the sales team, "how do we find our custome
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    rs?" Reply "we don't, everyone knows (name of company)". That busine
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    s was dying. After much deep root and branch change, which is anothe
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    story, it did not die but I am sure you get my point.

    Whether you
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    are CEO of a multinational or a one person business, without a marke
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ing strategy, your products and services will not reach any one.

    Ce
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    tral to that strategy is communication - using it to attract custome
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    rs and converting their interest in to sales. There are many tools f
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    r us to use ranging from direct mail and PR activities to web sites
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    nd even text messaging. The aim at all times must be to keep those c
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ustomers happy and coming back for more.

    How we market our business
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    is evident in the way we produce our letters, e-mails and brochures.
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    We must consistently convey the right image. Of course we must list
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    en to what our customers and prospects say and respond accordingly.
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    arketing should be on going, no matter how well we are doing.

    Succe
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    sful marketing need not be costly but it does mean that we must unde
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    rstand our market(s) and have an effective means to attract customer
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    to our products, services and business. Be vigilant and take action


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.subjects.org.ua/article/27767/subjects-Its-the-Marketing-that-Counts.html">It's the Marketing that Counts</a>

    BB link (for phorums):
    [url=http://www.subjects.org.ua/article/27767/subjects-Its-the-Marketing-that-Counts.html]It's the Marketing that Counts[/url]

    Related Articles:

    Unlocking Hidden Profits in Your Business

    5 Ways to Move Your Company Grant Program to a Strategic Philanthrop Program

    How to Build your own Affiliate sites

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com